Recombinant multi-species SLC22A15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC22A15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Organic ion transporters, such as SLC22A15, transport various medically and physiologically important compounds, including pharmaceuticals, toxins, hormones, neurotransmitters, and cellular metabolites. These transporters are also referred to as amphiphilic solute facilitators (ASFs).[supplied by OMIM, Apr 2004]
The Alternative Names of target: 2610034P21Rik,4930477M19,A530052I06Rik,FLIPT1,Fly-like putative transporter 1 (Flipt 1),PRO34686,SLC22A15,Slc22a15,Solute carrier family 22 member 15
Go
to SLC22A15 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP1660-Ag-1/ GM-Tg-hg-IP1660-Ag-2 | Human SLC22A15 protein | Human |
| GM-Tg-rg-IP1660-Ag-1/ GM-Tg-rg-IP1660-Ag-2 | Rat SLC22A15 protein | Rat |
| GM-Tg-mg-IP1660-Ag-1/ GM-Tg-mg-IP1660-Ag-2 | Mouse SLC22A15 protein | Mouse |
| GM-Tg-cynog-IP1660-Ag-1/ GM-Tg-cynog-IP1660-Ag-2 | Cynomolgus/Rhesus macaque SLC22A15 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP1660-Ag-1/ GM-Tg-felg-IP1660-Ag-2 | Feline SLC22A15 protein | Feline |
| GM-Tg-cang-IP1660-Ag-1/ GM-Tg-cang-IP1660-Ag-2 | Canine SLC22A15 protein | Canine |
| GM-Tg-bovg-IP1660-Ag-1/ GM-Tg-bovg-IP1660-Ag-2 | Bovine SLC22A15 protein | Bovine |
| GM-Tg-equg-IP1660-Ag-1/ GM-Tg-equg-IP1660-Ag-2 | Equine SLC22A15 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP1660-Ag-1/ GM-Tg-hg-IP1660-Ag-2;
GM-Tg-rg-IP1660-Ag-1/ GM-Tg-rg-IP1660-Ag-2;
GM-Tg-mg-IP1660-Ag-1/ GM-Tg-mg-IP1660-Ag-2; GM-Tg-cynog-IP1660-Ag-1/ GM-Tg-cynog-IP1660-Ag-2; GM-Tg-felg-IP1660-Ag-1/ GM-Tg-felg-IP1660-Ag-2; GM-Tg-cang-IP1660-Ag-1/ GM-Tg-cang-IP1660-Ag-2; GM-Tg-bovg-IP1660-Ag-1/ GM-Tg-bovg-IP1660-Ag-2; GM-Tg-equg-IP1660-Ag-1/ GM-Tg-equg-IP1660-Ag-2 |
| Products Name | SLC22A15 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SLC22A15 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC22A15 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.